Laboratory practices for reporting bacterial susceptibility tests that affect antibiotic therapy

Ronald B Schifman, Ales Pindur, John A. Bryan

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Objective. - To evaluate a laboratory-based process for integrating antimicrobial susceptibility, pharmacy, and clinical data with rapid physician notification to improve the care and outcome of patients with bacterial infections. Design. - Randomized case control study comparing standard microbiology reporting method with a targeted notification procedure. Results. - Of 254 cases studied, a discordance between antimicrobial susceptibility test results and antibiotic therapy was detected in 140 (55%) patients and confirmed after clinical review in 49 (19%). Appropriate changes in antibiotic therapy were made significantly sooner and in a significantly higher proportion of cases with targeted notification than with standard reporting procedures. Conclusions. - Utilization of antimicrobial susceptibility results is improved by integrating clinical and therapeutic information to identify cases that require physician notification, as measured by the timeliness and appropriateness of antibiotic treatment.

Original languageEnglish (US)
Pages (from-to)1168-1170
Number of pages3
JournalArchives of Pathology and Laboratory Medicine
Volume121
Issue number11
StatePublished - 1997
Externally publishedYes

Fingerprint

Anti-Bacterial Agents
Physicians
Therapeutics
Microbiology
Bacterial Infections
Case-Control Studies
Patient Care

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Medical Laboratory Technology

Cite this

Laboratory practices for reporting bacterial susceptibility tests that affect antibiotic therapy. / Schifman, Ronald B; Pindur, Ales; Bryan, John A.

In: Archives of Pathology and Laboratory Medicine, Vol. 121, No. 11, 1997, p. 1168-1170.

Research output: Contribution to journalArticle

@article{cb6827a2f8ad4d1f982e66b0087feb6a,
title = "Laboratory practices for reporting bacterial susceptibility tests that affect antibiotic therapy",
abstract = "Objective. - To evaluate a laboratory-based process for integrating antimicrobial susceptibility, pharmacy, and clinical data with rapid physician notification to improve the care and outcome of patients with bacterial infections. Design. - Randomized case control study comparing standard microbiology reporting method with a targeted notification procedure. Results. - Of 254 cases studied, a discordance between antimicrobial susceptibility test results and antibiotic therapy was detected in 140 (55{\%}) patients and confirmed after clinical review in 49 (19{\%}). Appropriate changes in antibiotic therapy were made significantly sooner and in a significantly higher proportion of cases with targeted notification than with standard reporting procedures. Conclusions. - Utilization of antimicrobial susceptibility results is improved by integrating clinical and therapeutic information to identify cases that require physician notification, as measured by the timeliness and appropriateness of antibiotic treatment.",
author = "Schifman, {Ronald B} and Ales Pindur and Bryan, {John A.}",
year = "1997",
language = "English (US)",
volume = "121",
pages = "1168--1170",
journal = "Archives of Pathology and Laboratory Medicine",
issn = "0003-9985",
publisher = "College of American Pathologists",
number = "11",

}

TY - JOUR

T1 - Laboratory practices for reporting bacterial susceptibility tests that affect antibiotic therapy

AU - Schifman, Ronald B

AU - Pindur, Ales

AU - Bryan, John A.

PY - 1997

Y1 - 1997

N2 - Objective. - To evaluate a laboratory-based process for integrating antimicrobial susceptibility, pharmacy, and clinical data with rapid physician notification to improve the care and outcome of patients with bacterial infections. Design. - Randomized case control study comparing standard microbiology reporting method with a targeted notification procedure. Results. - Of 254 cases studied, a discordance between antimicrobial susceptibility test results and antibiotic therapy was detected in 140 (55%) patients and confirmed after clinical review in 49 (19%). Appropriate changes in antibiotic therapy were made significantly sooner and in a significantly higher proportion of cases with targeted notification than with standard reporting procedures. Conclusions. - Utilization of antimicrobial susceptibility results is improved by integrating clinical and therapeutic information to identify cases that require physician notification, as measured by the timeliness and appropriateness of antibiotic treatment.

AB - Objective. - To evaluate a laboratory-based process for integrating antimicrobial susceptibility, pharmacy, and clinical data with rapid physician notification to improve the care and outcome of patients with bacterial infections. Design. - Randomized case control study comparing standard microbiology reporting method with a targeted notification procedure. Results. - Of 254 cases studied, a discordance between antimicrobial susceptibility test results and antibiotic therapy was detected in 140 (55%) patients and confirmed after clinical review in 49 (19%). Appropriate changes in antibiotic therapy were made significantly sooner and in a significantly higher proportion of cases with targeted notification than with standard reporting procedures. Conclusions. - Utilization of antimicrobial susceptibility results is improved by integrating clinical and therapeutic information to identify cases that require physician notification, as measured by the timeliness and appropriateness of antibiotic treatment.

UR - http://www.scopus.com/inward/record.url?scp=0031412628&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031412628&partnerID=8YFLogxK

M3 - Article

VL - 121

SP - 1168

EP - 1170

JO - Archives of Pathology and Laboratory Medicine

JF - Archives of Pathology and Laboratory Medicine

SN - 0003-9985

IS - 11

ER -